Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO. (Q36857470)
Jump to navigation
Jump to search
scientific article published on 23 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO. |
scientific article published on 23 April 2013 |
Statements
1 reference
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO. (English)
1 reference
L Favier
1 reference
B Weber
1 reference
C Roemer-Becuwe
1 reference
M Fabbro
1 reference
A Floquet
1 reference
F Joly
1 reference
A Plantade
1 reference
D Paraiso
1 reference
E Pujade-Lauraine
1 reference
1 reference
Identifiers
1 reference